Header Logo

Lauren Dockery

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local
5
2026
347
1.570
 Why?
Ovarian Neoplasms
7
2026
607
1.410
 Why?
Uterine Cervical Neoplasms
2
2022
304
1.050
 Why?
Endometrial Neoplasms
2
2025
189
0.850
 Why?
Vulvar Neoplasms
1
2021
25
0.680
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
38
0.670
 Why?
Carcinoma in Situ
1
2021
46
0.670
 Why?
Disease Management
1
2021
91
0.640
 Why?
Platinum Compounds
1
2019
14
0.620
 Why?
Patient Navigation
1
2018
8
0.560
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
433
0.560
 Why?
United States Indian Health Service
1
2018
18
0.560
 Why?
Phthalazines
1
2017
25
0.530
 Why?
Piperazines
1
2017
50
0.530
 Why?
Neoplasms, Glandular and Epithelial
1
2017
72
0.520
 Why?
Antineoplastic Agents
1
2019
686
0.410
 Why?
Indians, North American
1
2018
544
0.400
 Why?
Female
11
2026
15634
0.340
 Why?
Bevacizumab
2
2022
106
0.330
 Why?
Aged
6
2026
5599
0.300
 Why?
Molecular Targeted Therapy
2
2020
137
0.290
 Why?
Humans
11
2026
28884
0.250
 Why?
Retrospective Studies
4
2024
2635
0.240
 Why?
Aged, 80 and over
3
2025
2065
0.240
 Why?
Granulosa Cell Tumor
1
2026
4
0.240
 Why?
CD47 Antigen
1
2025
4
0.230
 Why?
CD40 Antigens
1
2025
14
0.220
 Why?
Machine Learning
1
2025
96
0.210
 Why?
Middle Aged
5
2026
7416
0.210
 Why?
Neoadjuvant Therapy
1
2024
80
0.200
 Why?
Prealbumin
1
2022
4
0.200
 Why?
Endometrium
1
2022
39
0.180
 Why?
Cervix Uteri
1
2022
65
0.180
 Why?
Indoles
1
2022
111
0.170
 Why?
Adult
4
2026
8030
0.170
 Why?
Vulvar Lichen Sclerosus
1
2021
1
0.170
 Why?
Vulva
1
2021
5
0.170
 Why?
Indazoles
1
2020
18
0.160
 Why?
Papillomaviridae
1
2021
90
0.160
 Why?
Fallopian Tube Neoplasms
1
2020
53
0.160
 Why?
Piperidines
1
2020
48
0.160
 Why?
Peritoneal Neoplasms
1
2020
80
0.160
 Why?
Disease-Free Survival
1
2019
236
0.150
 Why?
Papillomavirus Infections
1
2021
149
0.150
 Why?
Patient Compliance
1
2018
76
0.140
 Why?
Clinical Trials, Phase II as Topic
1
2017
26
0.140
 Why?
Disease Progression
1
2019
477
0.140
 Why?
Clinical Trials, Phase I as Topic
1
2017
32
0.140
 Why?
Treatment Outcome
2
2020
2426
0.120
 Why?
Randomized Controlled Trials as Topic
1
2017
404
0.120
 Why?
Age Factors
1
2017
737
0.120
 Why?
Risk Factors
1
2021
2127
0.110
 Why?
Prospective Studies
1
2017
1280
0.100
 Why?
United States
1
2018
2225
0.090
 Why?
Young Adult
1
2018
2839
0.080
 Why?
Adolescent
1
2018
3197
0.080
 Why?
Immunoglobulin Fc Fragments
1
2025
5
0.060
 Why?
Recombinant Fusion Proteins
1
2025
233
0.050
 Why?
Drug Resistance, Neoplasm
1
2025
170
0.050
 Why?
Interleukin-8
1
2022
45
0.050
 Why?
Cytoreduction Surgical Procedures
1
2022
33
0.050
 Why?
Vitamin D
1
2022
51
0.050
 Why?
Predictive Value of Tests
1
2024
485
0.050
 Why?
Chemotherapy, Adjuvant
1
2022
118
0.050
 Why?
Interleukin-6
1
2022
198
0.040
 Why?
Pilot Projects
1
2022
464
0.040
 Why?
Biomarkers
1
2022
777
0.040
 Why?
Prognosis
1
2020
811
0.030
 Why?
Postoperative Complications
1
2022
634
0.030
 Why?
Dockery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (24)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_